Articles

Read the latest articles relevant to your clinical practice, including exclusive insights from Healthed surveys and polls.

By reading selected clinical articles, you earn CPD in the Educational Activities (EA) category whenever you click the “Claim CPD” button and follow the prompts. 

Filter results

As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.

It has been a wild week for public messaging about the AstraZeneca COVID-19 vaccine — baffling both for the public and for general practitioners like me.

If you’re like the majority of general practices in Australia, you will be flat out juggling consents, documents and actual jabs be it AstraZeneca and/or Pfizer in the quest to conquer COVID.

Well, if nothing else, it looks as though GPs are ready to race through to stage 4 of the COVID recovery plan.

Pfizer remains the “preferred” vaccine for Australians aged under 40, due to a small but real increased risk of a rare clotting disorder.

As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.

Clinical Articles iconClinical Articles

It has been a wild week for public messaging about the AstraZeneca COVID-19 vaccine — baffling both for the public and for general practitioners like me.

Clinical Articles iconClinical Articles

If you’re like the majority of general practices in Australia, you will be flat out juggling consents, documents and actual jabs be it AstraZeneca and/or Pfizer in the quest to conquer COVID.

Clinical Articles iconClinical Articles

Well, if nothing else, it looks as though GPs are ready to race through to stage 4 of the COVID recovery plan.

Clinical Articles iconClinical Articles

Pfizer remains the “preferred” vaccine for Australians aged under 40, due to a small but real increased risk of a rare clotting disorder.

Clinical Articles iconClinical Articles